This blog contains content relating to early mortality due to Type 1 Diabetes, which may be confronting and distressing to some readers. Please exercise caution and care when engaging with […]
T1D Index
Honouring Peter Oliver’s life and legacy
September 23, 2022 JDRF is deeply saddened by the loss of an incredible individual who made an unparalleled impact at JDRF, Peter Oliver. “Peter possessed a multitude of qualities that defined […]
Not all sugars are the same: Using glucose to treat hypoglycemia
The following is sponsored content developed in partnership with AMG Medical Low blood glucose—also known as hypoglycemia—can be one of the most challenging, stressful, and often scary parts of living […]
JDRF commissions cost effectiveness study to demonstrate real quality of life value of diabetes technologies
JDRF’s #AccessForAll advocacy campaign aims to make type 1 diabetes (T1D) technology affordable and accessible for all Canadians living with the disease. With support from the T1D community, JDRF seeks […]
Dr. Tricia Tang Receives Funding Award through a JDRF – Michael Smith Health Research BC Partnership
JDRF Canada is thrilled to partner with Michael Smith Health Research BC to award type 1 diabetes (T1D) researcher Dr. Tricia Tang a Health Research BC Health Professional-Investigator (HP-I) award. […]
McGill University Health Centre designated provincial centre for islet transplantation for patients with type 1 diabetes
JDRF congratulates the McGill University Health Centre (MUHC) on its recent mandate to provide islet transplantation for persons with T1D in Quebec. This designation by Quebec’s Ministry of Health and […]
JDRF ambassador Sébastien Sasseville takes on the Race Across America in latest of endurance races
Sébastien was diagnosed with type 1 diabetes (T1D) in 2002. He made a commitment to himself then that T1D would never keep him from living life to the fullest, and […]
COVID-19 Vaccine Approved by Health Canada now approved for kids six months to 5
Update: July 15, 2022 On Thursday, July 14, 2022 Health Canada approved the Moderna Spikevax Covid-19 vaccine for children aged six months to five years old. This makes approximately 1.7 […]
Vertex Pharmaceuticals announces they have acquired ViaCyte
On Monday July 11, 2022, Vertex Pharmaceuticals announced they acquired ViaCyte for $320 million in cash to help speed up the development of VX-880, Vertex’s stem cell-derived therapy for people […]
Armour Transport Systems Reaches Million-Dollar Milestone for Type 1 Diabetes Research
It often starts with one and becomes a reality with the support of many: one step to begin a walk, one truck to build a transport empire, and one idea […]
Annual American Diabetes Association Conference showcases exciting developments in type 1 diabetes research
The American Diabetes Association’s 82nd Scientific Sessions, were held from June 3-7 both in person and virtually. This annual conference brings together researchers and scientists to both present and learn […]
Back together again
The 2022 Sun Life Walk to Cure Diabetes for JDRF was a huge success! The Walk is the largest fundraising event in Canada to support type 1 diabetes (T1D) research. […]
